Greenwood Capital Associates’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.96M Buy
22,013
+7,218
+49% +$2.15M 0.66% 50
2025
Q4
$4.88M Sell
14,795
-266
-2% -$90.1K 0.53% 66
2025
Q3
$5.2M Buy
15,061
+6,942
+86% +$2.1M 0.6% 57
2025
Q2
$2.53M Buy
+8,119
New +$3.1M 0.32% 88
2024
Q2
Sell
-13,226
Closed -$6.54M 260
2024
Q1
$6.54M Buy
13,226
+294
+2% +$149K 0.87% 39
2023
Q4
$6.81M Buy
+12,932
New +$6.9M 0.88% 42
2023
Q2
Sell
-427
Closed -$202K 254
2023
Q1
$202K Sell
427
-287
-40% -$138K 0.03% 227
2022
Q4
$379K Hold
714
0.06% 183
2022
Q3
$361K Hold
714
0.06% 194
2022
Q2
$366K Buy
714
+431
+152% +$216K 0.06% 185
2022
Q1
$144K Sell
283
-427
-60% -$206K 0.04% 142
2021
Q4
$356K Buy
+710
New +$321K 0.05% 195
2021
Q1
Sell
-392
Closed -$137K 233
2020
Q4
$137K Buy
+392
New +$131K 0.02% 201

Other funds holding UNH

Greenwood Capital Associates's UNH Position: Q1 2026 in Review

Greenwood Capital Associates increased its UnitedHealth (UNH) stake by 49% in Q1 2026, buying an estimated $2.15M and bringing the position to 22,013 shares worth $5.96M. The position accounts for 0.66% of the portfolio, ranked #50.

Greenwood Capital Associates first reported a position in UNH in Q4 2020 and has held it in 13 quarters since. The position peaked at $6.81M in Q4 2023. 3,021 funds tracked by Wall St. Rank hold UNH as of Q1 2026.

  • Greenwood Capital Associates held 22,013 shares of UnitedHealth worth $5.96M as of Q1 2026.
  • Greenwood Capital Associates bought 7,218 UnitedHealth shares in Q1 2026, an estimated $2.15M.
  • UnitedHealth made up 0.66% of Greenwood Capital Associates's portfolio in Q1 2026, its #50 holding.
  • Greenwood Capital Associates first reported a position in UnitedHealth in Q4 2020 and has held it in 13 quarters since.
  • Greenwood Capital Associates's UnitedHealth position peaked at $6.81M in Q4 2023.
  • 3,021 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.

Based on Greenwood Capital Associates's 13F filing for Q1 2026, filed 29 Apr 2026.